Cargando…
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214808/ https://www.ncbi.nlm.nih.gov/pubmed/28096680 http://dx.doi.org/10.4137/BCBCR.S12443 |